Table 2 Comparison between serum levels of lactate and autophagy-related 5 (ATG-5) and Parkin in multiple sclerosis (MS) patients analyzed as a whole and grouped according to magnetic resonance imaging (MRI) evidence of disease activity
| Â | Â | Serum lactate levels (nmol/ml) |
|---|---|---|
MS (n = 60) | ||
 Serum ATG-5 levels (pg/ml) | r = 0.5897; p < 0.0001 (Pearson) | |
 Serum Parkin levels (ng/ml) | r = 0.4855; p < 0.0001 (Pearson) | |
Gd− MS (n = 30) | ||
 Serum ATG-5 levels (pg/ml) | r = 0.1213; p = 5233 (Spearman) | |
 Serum Parkin levels (ng/ml) | r = − 0.3246; p = 0.0801 (Spearman) | |
Gd+ MS (n = 30) | ||
 Serum ATG-5 levels (pg/ml) | r = − 0.01697; p = 0.9291 (Spearman) | |
 Serum Parkin levels (ng/ml) | r = − 0.08174; p = 0.6565 (Spearman) | |